Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation.

Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation.

Item
http://www.wikidata.org/entity/Q55473891
Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoterExpression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma.Dendritic cell-based immunotherapy for malignant gliomas.Intratumoral INF-γ triggers an antiviral state in GL261 tumor cells: a major hurdle to overcome for oncolytic vaccinia virus therapy of cancer.Gamma interferon-mediated superinduction of B7-H1 in PTEN-deficient glioblastoma: a paradoxical mechanism of immune evasionImplications for immunotherapy of tumor-mediated T-cell apoptosis associated with loss of the tumor suppressor PTEN in glioblastoma.Regulatory landscape and clinical implication of MBD3 in human malignant glioma.Modulation of antigen-presenting cells by HDAC inhibitors: implications in autoimmunity and cancer.Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model.Contrasting effects of IFNα on MHC class II expression in professional vs. nonprofessional APCs: Role of CIITA type IV promoter.PD-L1 expression in medulloblastoma: an evaluation by subgroup.MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells.
P2860

Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation.

Item
http://www.wikidata.org/entity/Q55473891
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Malignant glioma cells use MHC ...... and CD4(+) T-cell activation.
@en
Malignant glioma cells use MHC class II transactivator
@nl
type
label
Malignant glioma cells use MHC ...... and CD4(+) T-cell activation.
@en
Malignant glioma cells use MHC class II transactivator
@nl
prefLabel
Malignant glioma cells use MHC ...... and CD4(+) T-cell activation.
@en
Malignant glioma cells use MHC class II transactivator
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Malignant glioma cells use MHC ...... g and CD4(+) T-cell activation
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698